Intas derives its competitive edge from successful and strategic moves it has made in the areas of manufacturing, R & D, biotechnology and global operations.

• The current decade has witnessed Intas fortifying its presence in the segments of CNS, Cardiovascular, Diabetology, Gastroenterology, Urology and Pain management

• It has ventured successfully into high-growth areas of Animal Health Care, Oncology and Biotechnology to augment its base

• Its state-of-the-art manufacturing facility for Cytotoxic products is one of its kind in the entire Asia-Pacific region

• Through strategic investment in the manufacturing facility at Matoda (District: Moraiya), Gujarat, Intas has upgraded its manufacturing capabilities. It has the regulatory approval of agencies like FDA, MHRA, TGA, ANVISA and MCC

• A modern manufacturing facility set up at Dehradun (Uttarakhand, North India) has further synergised the manufacturing capabilities to meet the increasing demand

• Intas has its presence in 42 countries worldwide and has made successful forays into contract manufacturing and contract marketing tie-ups across the world